Modeling a congenital disorder of glycosylation type I in C. elegans: A genome-wide RNAi screen for N-glycosylation-dependent loci

Glycobiology

Volumn 19, Issue 12, 2009, Pages 1554-1562

  Struwe, Weston B ^a   Hughes, Bethany L ^a   Osborn, David W ^a   Boudreau, Erica D ^a   Shaw, Kristin M D ^a   Warren, Charles E ^a  

^a UNIVERSITY OF NEW HAMPSHIRE   (United States)

Author keywords

C. elegans; Congenital disorders of glycosylation; Lipid linked oligosaccharide; RNAi; Tunicamycin

Indexed keywords

GENE PRODUCT; TUNICAMYCIN;

ARTICLE; CAENORHABDITIS ELEGANS; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 1; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENETIC IDENTIFICATION; GENETIC SCREENING; LETHALITY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RNA INTERFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; CAENORHABDITIS ELEGANS; CARBOHYDRATE METABOLISM, INBORN ERRORS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; GENETIC LOCI; GLYCOSYLATION; HUMANS; PHENOTYPE; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUNICAMYCIN;

CAENORHABDITIS ELEGANS;

EID: 71049129783     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp136     Document Type: Article

References (40)

1. Aebi M, Hennet T. 2001. Congenital disorders of glycosylation: Genetic model systems lead the way. Trends Cell Biol. 11:136-141.
2. Asikainen S, Vartiainen S, Lakso M, Nass R, Wong G. 2005. Selective sensitivity of Caenorhabditis elegans neurons to RNA interference. Neuroreport. 16:1995-1999.
3. Barnes G, Hansen WJ, Holcomb CL, Rine J. 1984. Asparagine-linked glycosylation in Saccharomyces cerevisiae: Genetic analysis of an early step. Mol Cell Biol. 4:2381-2388.
4. Belden WJ, Barlowe C. 2001. Deletion of yeast p24 genes activates the unfolded protein response. Mol Biol Cell. 12:957-969.
5. Berninsone PM. 2006. Carbohydrates and glycosylation (December 18, 2006). In: The C. elegans Research Community, editor. WormBook.
6. Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics. 77:71-94.
7. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 415:92-96.
8. de Lonlay P, Seta N, et al. 2001. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: A series of 26 cases. J Med Genet. 38:14-19.
9. Eklund EA, Freeze HH. 2006. The congenital disorders of glycosylation: A multifaceted group of syndromes. NeuroRx. 3:254-263.
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806-811.
11. Freeze HH, Westphal V. 2001. Balancing N-linked glycosylation to avoid disease. Biochimie. 83:791-799.
12. Hope IA. 1999. C. elegans: A Practical Approach. Oxford, New York: Oxford University Press.
13. Hwang HY, Horvitz HR. 2002. The SQV-1 UDP-glucuronic acid decarboxylase and the SQV-7 nucleotide-sugar transporter may act in the Golgi apparatus to affect Caenorhabditis elegans vulval morphogenesis and embryonic development. Proc Natl Acad Sci USA. 99:14218-14223.
14. Jaeken J, Matthijs G. 2001. Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet. 2:129-151.
15. Jaeken J, Matthijs G. 2007. Congenital disorders of glycosylation: A rapidly expanding disease family. Annu Rev Genomics Hum Genet. 8:261-278.
16. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, et al. 2003. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 421:231-237.
17. Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J. 2001. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2: RESEARCH0002.
18. Lehle L, Strahl S, et al. 2006. Protein glycosylation, conserved from yeast to man: A model organism helps elucidate congenital human diseases. Angew Chem Int Ed Engl. 45:6802-6818.
19. Link CD, Silverman MA, Breen M, Watt KE, Dames SA. 1992. Characterization of Caenorhabditis elegans lectin-binding mutants. Genetics. 131:867-881.
20. Matthijs G, Schollen E, Bjursell C, Erlandson A, Freeze H, Imtiaz F, Kjaergaard S, Martinsson T, Schwartz M, Seta N, et al. 2000. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat. 16:386-394.
21. Mills P, Mills K, Clayton P, Johnson A, Whitehouse D, Winchester B. 2001. Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation. Biochem J. 359:249-254.
22. Mohler WA, Shemer G, del Campo JJ, Valansi C, Opoku-Serebuoh E, Scranton V, Assaf N, White JG, Podbilewicz B. 2002. The type I membrane protein EFF-1 is essential for developmental cell fusion. Dev Cell. 2:355-362.
23. Paschinger K, Gutternigg M, Rendic D, Wilson IB. 2008. The N glycosylation pattern of Caenorhabditis elegans. Carbohydr Res. 343:2041-2049.
24. Prietsch V, Peters V, Hackler R, Jakobi R, Assmann B, Fang J, Korner C, Helwig-Rolig A, Schaefer JR, Hoffmann GF. 2002. A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. J Inherit Metab Dis. 25:126-130.
25. Rual JF, Ceron J, et al. 2004. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res. 14:2162-2168.
26. Schachter H. 2004. Protein glycosylation lessons from Caenorhabditis elegans. Curr Opin Struct Biol. 14:607-616.
27. Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. 2000. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet. 8:367-371.
28. Shen X, Ellis RE, et al. 2001. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell. 107:893-903.
29. Simmer F, Moorman C, et al. 2003. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 1:E12.
30. Springer W, Hoppe T, Schmidt E, Baumeister R. 2005. A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress. Hum Mol Genet. 14:3407-3423.
31. Sundaram M, Greenwald I. 1993. Suppressors of a lin-12 hypomorph define genes that interact with both lin-12 and glp-1 in Caenorhabditis elegans. Genetics. 135:765-783.
32. Tatusov RL, Fedorova ND, et al. 2003. The COG database: An updated version includes eukaryotes. BMC Bioinformatics. 4:41.
33. Thorpe CJ, Schlesinger A, Bowerman B. 2000. Wnt signalling in Caenorhabditis elegans: Regulating repressors and polarizing the cytoskeleton. Trends Cell Biol. 10:10-17.
34. Ungar D, Oka T, Krieger M, Hughson FM. 2006. Retrograde transport on the COG railway. Trends Cell Biol. 16:113-120.
35. Vodopiutz J, Bodamer OA. 2008. Congenital disorders of glycosylation - A challenging group of IEMs. J Inherit Metab Dis. 31:267-269.
36. Wen C, Greenwald I. 1999. p24 proteins and quality control of LIN-12 and GLP-1 trafficking in Caenorhabditis elegans. J Cell Biol. 145:1165-1175.
37. Westphal V, Kjaergaard S, Schollen E, Martens K, Grunewald S, Schwartz M, Matthijs G, Freeze HH. 2002. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency. Hum Mol Genet. 11:599-604.
38. Wu X, Rush JS, Karaoglu D, Krasnewich D, Lubinsky MS, Waechter CJ, Gilmore R, Freeze HH. 2003. Deficiency of UDP-GlcNAc:dOlichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij. Hum Mutat. 22:144-150.
39. Zeevaert R, Foulquier F, Jaeken J, Matthijs G. 2008. Deficiencies in subunits of the Conserved Oligomeric Golgi (COG) complex define a novel group of congenital disorders of glycosylation. Mol Genet Metab. 93:15-21.
40. Zhu X, Zeng Y, Lehrman MA. 1992. Evidence that the hamster tunicamycin resistance gene encodes UDP-GlcNAc:dOlichol phosphate N acetylglucosamine-1-phosphate transferase. J Biol Chem. 267:8895-8902.